News & Events about Myriad Genetics Inc.
Globe Newswire
5 months ago
Myriad to support MD Anderson researchers studying metastatic renal cell carcinoma treatment selection and responseSALT LAKE CITY, June 12, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced an agreement with The ...
Globe Newswire
7 months ago
New program will increase access to affordable genetic testing while also helping to identify and elevate high-risk patient careSALT LAKE CITY, April 12, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and SimonMed Imaging, one of ...
Ticker Report
8 months ago
Myriad Genetics, Inc. (NASDAQ:MYGN Get Rating) COO Nicole Lambert sold 6,433 shares of the companys stock in a transaction dated Monday, March 27th. The shares were sold at an average price of $23.48, for a total transaction of $151,046.84. Following the completion of the transaction...
Myriad Genetics, Inc. (NASDAQ:MYGN Get Rating) COO Nicole Lambert sold 6,433 shares of the companys stock in a transaction dated Monday, March 27th. The shares were sold at an average price of $23.48, for a total transaction of $151,046.84. Following the completion of the transaction...
Globe Newswire
9 months ago
Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industrySALT LAKE CITY, March 02, 2023 (GLOBE NEWSWIRE) -- Myriad Genetic, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Illumina Inc. (...